Give the gift of healing: http://maps.org/donatetoday
In the Multidisciplinary Association for Psychedelic Studies (MAPS)' completed Phase 2 trials with 107 participants, 56% no longer qualified for PTSD after treatment with MDMA-assisted psychotherapy, measured two months following treatment. Learn more and donate: maps.org
MAPS is a non-profit research and educational organization working to develop contexts for careful, beneficial uses of psychedelics and marijuana.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of PTSD. MAPS and the FDA have also reached agreement under the Special Protocol Assessment Process (SPA) for the design of two upcoming Phase 3 trials of MDMA-assisted psychotherapy for patients with severe PTSD.
to learn more.
Your contribution to MAPS helps support the creation of evidence-based treatments for PTSD and other conditions using psychedelic medicines.
Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist psychotherapy for the treatment of posttraumatic stress disorder (PTSD). We are also sponsoring ongoing clinical trials of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness, and MDMA-assisted therapy for social anxiety in autistic adults.
MAPS has completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s.
*Ibogaine Therapy for Drug Addiction*
We are studying the long-term effects of ibogaine treatment on patients presently undergoing therapy at independent ibogaine treatment centers in Mexico and New Zealand.
MAPS supports research into the safety and effectiveness of ayahuasca-assisted treatment for drug addiction and PTSD. We also support conferences, meetings, and publications about the scientific, therapeutic, sustainable, and spiritual uses of ayahuasca.
MAPS has received regulatory approval to conduct a study of smoked marijuana for symptoms of posttraumatic stress disorder (PTSD) in veterans of war.
Learn more about MAPS and support psychedelic research:
—Editor: Andrew O'Keefe (http://andrewjokeefe.com)
—Editor: Renee Rosky
—Music: Erothyme - Relief Remains (http://erothyme.net)
—Additional footage: ENDPAIN (http://endpain.com)
Support psychedelic science: http://maps.org